How an AI solution can design new tuberculosis drug regimens

Posted · Add Comment

With a shortage of new tuberculosis drugs in the pipeline, a software tool can predict how current drugs–including unlikely candidates — can be combined in new ways to create more effective treatments.

This full article appears on <a href="">Science Daily</a>

Leave a Reply

Your email address will not be published. Required fields are marked *